ONS-ONCC Chemotherapy Immunotherapy Certification 2025 Brand New Exam Prep Guide Updated Questions with Correct Answers 2026/2027

Pass the ONS-ONCC Chemotherapy Immunotherapy Certification exam with this brand new 2025 exam prep guide featuring updated questions and correct answers for 2026/2027. Master all essential oncology nursing topics including cancer biology (oncogenes EGFR Erb-B1 HER2, tumor suppressor gene p53 suicide gene, proto-oncogenes normal cell growth), treatment modalities (neoadjuvant therapy shrink tumor before main treatment, adjuvant therapy after primary treatment to lower recurrence risk), chemotherapy agents (alkylating agents cytotoxin ifos bendamustine DNA helix break, platinum-based cisplatin carboplatin no alkyl group, antimetabolites myelosuppression GI toxicity photosensitivity hand-foot syndrome, antitumor antibiotics lifetime doses cardiotoxicity, anthracyclines doxorubicin daunorubicin epirubicin idarubicin, non-anthracyclines actinomycin D mitomycin C bleomycin, plant alkaloids etoposide docetaxel paclitaxel vinblastine vinorelbine), specific drug toxicities (oxaliplatin cold avoidance 3-4 days, streptozocin semustine most nephrotoxic, bleomycin pulmonary fibrosis lifetime dose, lymphoma patients higher anaphylaxis risk), hematopoiesis and immunity (myeloid lineage RBC WBC platelets, lymphoid lineage lymphocytes, granulocytes basophils eosinophils neutrophils, agranulocytes T cells B cells monocytes, innate immunity first line non-specific, adaptive immunity humoral B cells antibodies cell-mediated cytotoxic T cells helper T cells regulatory T cells suppressor, cytokines stimulate macrophages cytotoxic T cells), and clinical calculations (ANC calculation %polys + %bands x WBC/100). Perfect for oncology nurses seeking ONS-ONCC chemotherapy immunotherapy certification.